Abbott V, Housden B, Houldsworth A
Brain Commun. 2025; 7(2):fcaf092.
PMID: 40078868
PMC: 11896979.
DOI: 10.1093/braincomms/fcaf092.
Xie L, Zhang K, Pan K, Su X, Zhao X, Li R
J Transl Med. 2025; 23(1):304.
PMID: 40065372
PMC: 11895318.
DOI: 10.1186/s12967-025-06268-x.
Murali P, Kavitha B, Narasimhan M
J Pharm Bioallied Sci. 2025; 16(Suppl 5):S4210-S4220.
PMID: 40061651
PMC: 11888656.
DOI: 10.4103/jpbs.jpbs_517_24.
Joudi A, Gurkan J, Liu Q, Acosta M, Helmin K, Morales-Nebreda L
bioRxiv. 2025; .
PMID: 40060513
PMC: 11888461.
DOI: 10.1101/2025.02.25.640199.
Zhang H, Podesta M, Cavazzoni C, Wu Y, Lee J, Li X
Nat Commun. 2025; 16(1):2151.
PMID: 40038336
PMC: 11880397.
DOI: 10.1038/s41467-025-57468-4.
Nasal anti-CD3 monoclonal antibody ameliorates traumatic brain injury, enhances microglial phagocytosis and reduces neuroinflammation via IL-10-dependent T-microglia crosstalk.
Izzy S, Yahya T, Albastaki O, Abou-El-Hassan H, Aronchik M, Cao T
Nat Neurosci. 2025; 28(3):499-516.
PMID: 40016353
PMC: 11893472.
DOI: 10.1038/s41593-025-01877-7.
in Inflammation and Pain: Update on Pathologic Mechanisms.
Rasquel-Oliveira F, Ribeiro J, Martelossi-Cebinelli G, Costa F, Nakazato G, Casagrande R
Pathogens. 2025; 14(2).
PMID: 40005560
PMC: 11858194.
DOI: 10.3390/pathogens14020185.
Alternative Splicing as a Modulator of the Interferon-Gamma Pathway.
Suri P, Badalov A, Ruggiu M
Cancers (Basel). 2025; 17(4).
PMID: 40002189
PMC: 11853465.
DOI: 10.3390/cancers17040594.
CCL20 in the tumor microenvironment: implications for cancer progression and therapeutic approaches.
Kwantwi L, Boafo J, Egleh B, Li M
Clin Transl Oncol. 2025; .
PMID: 39985603
DOI: 10.1007/s12094-025-03874-5.
Tissue levels of regulatory T cell related lncRNAs in lung cancer: evidence for dysregulation of immune responses.
Esfandi F, Hussen B, Abroudi A, Djamali M, Eslami S, Feghahati F
Discov Oncol. 2025; 16(1):221.
PMID: 39982571
PMC: 11845645.
DOI: 10.1007/s12672-025-01874-z.
A CD25-CCR7 complex initiates non-canonical IL-2 signaling.
Kim S, Lee H, Gingras A, Ley K, Spangler J, Ginsberg M
bioRxiv. 2025; .
PMID: 39975281
PMC: 11838579.
DOI: 10.1101/2025.02.03.636356.
Aberrant Subsets of Regulatory T Cells and their Correlations with Serum IL-2 in Patients with Rheumatoid Arthritis.
Zi X, Yan H, Li B, Gao C, Li X, Luo J
Inflammation. 2025; .
PMID: 39971881
DOI: 10.1007/s10753-025-02248-x.
Prebiotic selection influencing inflammatory bowel disease treatment outcomes: a review of the preclinical and clinical evidence.
Ariaee A, Koentgen S, Wardill H, Hold G, Prestidge C, Armstrong H
eGastroenterology. 2025; 2(2):e100055.
PMID: 39944472
PMC: 11731074.
DOI: 10.1136/egastro-2023-100055.
A new method for the reproducible development of aptamers (Neomers).
Meehan C, Hamilton E, Mansour C, Lecocq S, Drake C, An Y
PLoS One. 2025; 20(2):e0311497.
PMID: 39937840
PMC: 11819540.
DOI: 10.1371/journal.pone.0311497.
ACC1 is a dual metabolic-epigenetic regulator of Treg stability and immune tolerance.
Stuve P, Godoy G, Ferreyra F, Hellriegel F, Boukhallouk F, Kao Y
Mol Metab. 2025; 94:102111.
PMID: 39929287
PMC: 11893314.
DOI: 10.1016/j.molmet.2025.102111.
Human immune system: Exploring diversity across individuals and populations.
Hoang Nguyen K, Le N, Nguyen P, Nguyen H, Hoang D, Huynh C
Heliyon. 2025; 11(2):e41836.
PMID: 39911431
PMC: 11795082.
DOI: 10.1016/j.heliyon.2025.e41836.
Gene editing of CD3 epsilon to redirect regulatory T cells for adoptive T cell transfer.
Du W, Noyan F, McCallion O, Drosdek V, Kath J, Glaser V
Mol Ther. 2025; 33(3):997-1013.
PMID: 39905729
PMC: 11897813.
DOI: 10.1016/j.ymthe.2025.01.045.
Targeting HGF/c-MET signaling to regulate the tumor microenvironment: Implications for counteracting tumor immune evasion.
Xia Y, Huang C, Zhong M, Zhong H, Ruan R, Xiong J
Cell Commun Signal. 2025; 23(1):46.
PMID: 39856684
PMC: 11762533.
DOI: 10.1186/s12964-025-02033-1.
Metabolic reprogramming of naïve regulatory T cells by IL-7 and IL-15 promotes their persistence and performance upon adoptive transfer.
Filoni J, Ferrari A, Jofra T, Putignano A, Da Dalt L, Cesarano S
Commun Biol. 2025; 8(1):99.
PMID: 39838096
PMC: 11751088.
DOI: 10.1038/s42003-024-07381-1.
Heterochromatic gene silencing controls CD4 T cell susceptibility to regulatory T cell-mediated suppression in a murine allograft model.
Noguerol J, Laviolette K, Zahm M, Chaubet A, Sahal A, Detraves C
Nat Commun. 2025; 16(1):566.
PMID: 39794349
PMC: 11723947.
DOI: 10.1038/s41467-025-55848-4.
